Carl Graham
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Obstetrics and Gynecology top 10%
- COVID-19 Impact on Reproduction
Papers in
-
- SARS-CoV-2 and COVID-19 Research 13
- COVID-19 Clinical Research Studies 10
- Co-authors
- Katie J. Doores (18 shared papers)Michael H. Malim (15 shared papers)Jeffrey Seow (12 shared papers)Stuart J. D. Neil (3 shared papers)Manu Shankar‐Hari (1 shared paper)Michael J. Carter (1 shared paper)A.R. Jennings (1 shared paper)Paul Wellman (1 shared paper)
- Journals
- Cell Reports (3 papers)mBio (2 papers)Vaccines (2 papers)PLoS Pathogens (2 papers)Nature Communications (1 paper)
- Partner nations
- United KingdomAustraliaUganda
In The Last Decade
Carl Graham
25 papers receiving 683 citations
Peers
Comparison fields: 5 of 74
- Infectious Diseases 307
- Obstetrics and Gynecology 33
- Surgery 184
- Gastroenterology 23
- Immunology 93
Countries citing papers authored by Carl Graham
This map shows the geographic impact of Carl Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Graham more than expected).
Fields of papers citing papers by Carl Graham
This network shows the impact of papers produced by Carl Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Graham. The network helps show where Carl Graham may publish in the future.
Co-authors
The 25 scholars most cited alongside Carl Graham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 264 | |
| 2 | 2021 | 104 | |
| 3 | 2010 | 60 | |
| 4 | Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study | 2022 | 37 |
| 5 | 2021 | 31 | |
| 6 | 2013 | 28 | |
| 7 | 2022 | 25 | |
| 8 | 2021 | 23 | |
| 9 | 2022 | 19 | |
| 10 | 2019 | 18 | |
| 11 | 2022 | 17 | |
| 12 | Test of HIV incidence shows continuing HIV transmission in homosexual/bisexual men in England and Wales. | 2001 | 14 |
| 13 | 2004 | 13 | |
| 14 | 2022 | 11 | |
| 15 | 2016 | 8 | |
| 16 | 2022 | 6 | |
| 17 | 2022 | 5 | |
| 18 | 2023 | 5 | |
| 19 | 2025 | 2 | |
| 20 | 1965 | 2 |
About Carl Graham
Carl Graham is a scholar working on Infectious Diseases, Molecular Biology, Neurology, Immunology and Anesthesiology and Pain Medicine, having authored 25 papers that have together received 697 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (13 papers), COVID-19 Clinical Research Studies (10 papers), Long-Term Effects of COVID-19 (3 papers), Pain Management and Opioid Use (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Vaccine Coverage and Hesitancy (2 papers). The work is most often cited by research in Infectious Diseases (307 citations), Obstetrics and Gynecology (33 citations), Surgery (184 citations), Gastroenterology (23 citations) and Immunology (93 citations). Carl Graham has collaborated with scholars based in United Kingdom, Australia and Uganda. Frequent co-authors include Katie J. Doores, Michael H. Malim, Jeffrey Seow, Stuart J. D. Neil, Manu Shankar‐Hari, Michael J. Carter, A.R. Jennings, Paul Wellman, Shane M. Tibby and Emma Timms. Their work appears in journals such as Cell Reports, mBio, Vaccines, PLoS Pathogens and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.